Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Forte Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 24 | −9 |
| SharesConverted for a 1-for-25 split | 762.7K | 6.99K | 736.6K | −19.1K (−2.5%) |
| Value | $10.2M | $93.9K | $4.12M | −$6.03M (−59.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Forte Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 6,803 | $38.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 8 | $45 | 0.00% |
| Barclays PLC | 1 | $6 | 0.00% |
Sold out (12)
Institutions that held Forte Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Renaissance Technologies LLC | 133,400 | $71.6K |
| Two Sigma Investments, LP | 40,811 | $21.9K |
| State Street Corp | 37,564 | $20.2K |
| Sanctuary Advisors, LLC | 22,014 | $15.8K |
| Northern Trust Corp | 26,817 | $14.4K |
| Goldman Sachs Group Inc | 20,776 | $11.2K |
| Aries Wealth Management | 13,000 | $6.98K |
| HSBC Holdings PLC | 10,745 | $5.89K |
| Citadel Advisors LLC | 8,097 | $4.35K |
| FMR LLC | 128 | $69 |
| Qube Research & Technologies Ltd | 3 | $2 |
| Royal Bank of Canada | 137 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Forte Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 174,858 | $93.9K |